Table 1. Clinical characteristics by gender.

Characteristic		Men(N = 295)		Women(N = 189)		Total(N = 484)		P
		N	%	N	%	N	%
Age, year	Mean	60.1		60.7		60.4		0.495 b
	SD	10.1		9.8		9.9
Extent of disease	LAPC	49	16.6	47	24.9	96	19.8	0.026 a
	MPC	246	83.4	142	75.1	388	80.2
ECOGPS	0–1	240	81.4	153	81.0	393	81.2	0.912 a
	≥2	55	18.6	36	19.0	91	18.8
BMI at diagnosis, kg/m2(N = 480)	Mean	21.7		21.9		21.8		0.509 b
	SD	2.5		2.8		2.7
BMI at diagnosis (N = 480)	<20 kg/m2	70	23.9	48	25.7	118	24.6	0.527 a
	20–24.9 kg/m2	192	65.5	114	61.0	306	63.8
	≥25kg/m2	31	10.6	25	13.3	56	11.6
SMI at diagnosis, cm2/m2	Mean	47.7		38.6		44.0		< 0.001 b
	SD	7.1		5.4		7.8
Sarcopenia†	Yes	67	22.7	36	19.0	103	21.3	0.364 a
	No	228	77.3	153	81.0	381	78.7

LAPC, locally advanced pancreatic cancer; MPC, metastatic pancreatic cancer; ECOGPS, Eastern Cooperative Oncology Group performance status;BMI, body mass index; SMI, skeletal muscle index; SD, standard deviation.

^†Sarcopenia: males< 42.2 cm²/m², females< 33.9 cm²/m².

^a Pvalues were calculated using theFisher’s exact test.

^b Pvalues were calculated using theIndependent t-test.